Signal Transduction and Targeted Therapy Introduction

2019-12-24

Open the phone and scan

Signal Transduction and Targeted Therapy

Chief Editor

Prof. Carlo M. Croce
Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
Prof. Kang Zhang
Center for Biomedicine and Innovations at Faculty of Medicine, Macau University of Science and Technology, China
Prof. Yuquan Wei
National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, China

 

Profile

Signal Transduction and Targeted Therapy is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others. This journal is now indexed in Science Citation Index Expanded (SCIE), Journal Citation Reports/Science Edition, BIOSIS previews, Directory of Open Access Journals (DOAJ), PubMed Central (PMC) and Scopus.

 

Journal Metrics

The 2019 journal metrics for Signal Transduction and Targeted Therapy are as follows:

 

Citations

2 Year Impact Factor: 13.493*

5 Year Impact Factor: 13.195*

JCR Rank*: 9/297(Q1) BIOCHEMISTRY & MOLECULAR BIOLOGY, 14/195(Q1) CELL BIOLOGY

Immediacy Index: 0.791*

 



Last page：Molecular Biomedicine Introduction